Yamagata M, Kanematsu T, Matsumata T, Nishizaki T, Utsunomiya T, Sugimachi K, Okuda S
Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Hepatogastroenterology. 1993 Jun;40(3):249-52.
A review of seven hepatic resections in six patients undergoing maintenance hemodialysis is presented. These cases consisted of hepatocellular carcinoma in four, and cholangiocellular carcinoma, myelolipoma and focal nodular hyperplasia in one each. The last preoperative hemodialysis was undertaken within 24 h prior to the operation with heparin. Intraoperatively, infused solutions containing no potassium, along with strict attention to preventing overhydration, allowed us to manage the patients without hemodialysis on the day of the operation. No specific intra-operative complications related to hemodialysis were noted. Postoperative hemodialysis was performed on the first or second day after operation, using nafamstat mesilate, a synthetic protease-inhibiting agent. The morbidity rate in the hemodialyzed patients was 85.7% (6/7), which was significantly higher than that in the non-hemodialyzed patients who underwent hepatic resections in our hospital. Fluid collection in the pleural and/or peritoneal cavities was frequent and difficult to control, but transient. Our experience suggests that hepatic resection is an acceptable procedure for hemodialyzed patients, when used in conjunction with careful perioperative management.
本文报告了6例维持性血液透析患者的7例肝脏切除术。这些病例包括4例肝细胞癌,1例胆管细胞癌、1例髓脂肪瘤和1例局灶性结节性增生。术前最后一次血液透析在手术前24小时内使用肝素进行。术中,输注不含钾的溶液,并严格注意防止水合过度,使我们能够在手术当天不进行血液透析来管理患者。未发现与血液透析相关的特定术中并发症。术后在术后第一天或第二天进行血液透析,使用合成蛋白酶抑制剂甲磺酸萘莫司他。血液透析患者的发病率为85.7%(6/7),显著高于我院未进行血液透析的肝脏切除患者。胸腔和/或腹腔积液频繁且难以控制,但为一过性。我们的经验表明,结合精心的围手术期管理,肝脏切除术对于血液透析患者是一种可接受的手术。